Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives

Add time:08/25/2019    Source:sciencedirect.com

In this work, a new series of arysulfonylhydrazine-1H-1,2,3-triazole derivatives were synthesized, and their ability to inhibit the in vitro replication of HSV-1 was evaluated. Among the 1,2,3-triazole derivatives, 1-[(5″-methyl-1″-(4‴-fluorophenylamino)-1H-1,2,3-triazol-4″-yl)carbonyl]-2-(4′-methylphenylsulfonyl)hydrazine and 1-[(5′-methyl-1′-(2″,5″-dichlorophenylamino)-1H-1,2,3-triazol-4′-yl)carbonyl]-2-(phenylsulfonyl)hydrazine, with IC50 values of 1.30 and 1.26 μM, respectively, displayed potent activity against HSV-1. Because these compounds have low cytotoxicity, their selectivity indices are high. Under the assay conditions, they have better performance than does the reference compound acyclovir. The structures of all of the compounds were confirmed by one- and two-dimensional NMR techniques (1H, 13C-APT, COSY-1H × 1H and HETCOR 1JCH) and by elemental analysis.

We also recommend Trading Suppliers and Manufacturers of 1-(4-METHYLPHENYLSULFONYL)-1,2,4-TRIAZOLE (cas 13578-51-3). Pls Click Website Link as below: cas 13578-51-3 suppliers

Prev:Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) and response to epidermal growth factor
Next:Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenylurea) (LY181984) modulated by redox)